GS-441524 is a nucleoside analog compound widely referenced in veterinary antiviral discussions, particularly in relation to feline infectious peritonitis (FIP). The compound has been used in structured veterinary management programs designed to support cats diagnosed with this condition.
This formulation contains 20mg/ml GS-441524 and is supplied in a 6ml sterile vial, allowing convenient dosage adjustment according to body weight. The injectable format is often selected in veterinary practice because it allows predictable absorption and consistent administration during treatment cycles.
The product is manufactured in China and packaged in sealed vials for veterinary use and distribution through professional channels.
| Item | Details |
|---|---|
| Product Name | GS-441524 Injection |
| CAS Number | 1191237-69-0 |
| Concentration | 20mg/ml |
| Dosage Form | Injectable Solution |
| Vial Size | 6ml per vial |
| Storage Condition | Room Temperature |
| Shelf Life | 1 Year from Date of Manufacture |
| Country of Manufacture | China |
| Intended Use | Treatment for Cat FIP |
Each vial is labeled with production batch information to ensure traceability and quality monitoring.
Feline Infectious Peritonitis is a complex viral disease that develops when feline coronavirus mutates within the host. It can affect cats of different ages and breeds, and symptoms often vary depending on the form of the disease.
Veterinary professionals generally classify FIP into several categories:
Wet (Effusive) FIP – fluid accumulation in body cavities
Dry (Non-effusive) FIP – organ inflammation without fluid buildup
Ocular FIP – infection affecting eye tissues
Neurological FIP – involvement of the nervous system
Different forms of FIP may require adjustments to treatment dosage and duration.
The dosage of GS-441524 injection is usually calculated according to the cat’s body weight and the clinical type of FIP. The following dosage references are commonly used in treatment protocols.
| Condition | Dosage |
|---|---|
| Wet FIP | 0.3 ml/kg body weight + 0.1 ml residue |
| Dry FIP | 0.4 ml/kg body weight + 0.1 ml residue |
| Eye / Nerve Involvement | 0.5 ml/kg body weight + 0.1 ml residue |
| Recurrence | 0.6 ml/kg body weight + 0.1 ml residue |
During the treatment cycle, the cat’s weight should be monitored regularly so the dosage can be adjusted if necessary.
The 20mg/ml concentration is widely used in veterinary treatment protocols because it allows flexible dosing for cats with different body weights.
Key characteristics include:
Injectable formulation for systemic absorption
20mg/ml concentration suitable for standard dosing protocols
Compact 6ml vial size convenient for treatment planning
Room temperature storage simplifies transportation
Clearly labeled packaging for batch identification
These features make the product suitable for veterinary clinics, animal hospitals, and distributors working with feline health management.
For optimal stability and product quality:
Store at room temperature in a dry environment
Avoid exposure to excessive heat or direct sunlight
Keep the vial sealed until use
Follow sterile handling procedures during administration
When stored properly, the product maintains its quality for up to 12 months from the manufacturing date.
This product is commonly supplied to:
Veterinary clinics
Animal hospitals
Cat rescue organizations
Veterinary pharmaceutical distributors
Different packaging formats are available for distribution needs, and secure export packaging can be arranged for international shipments.
This product is intended for veterinary use only.
Dosage and treatment plans should always be determined by qualified veterinary professionals according to the cat’s clinical condition.
